Literature DB >> 23954784

The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases.

Takashi Minami1, Shuying Jiang, Keri Schadler, Jun-Ichi Suehiro, Tsuyoshi Osawa, Yuichi Oike, Mai Miura, Makoto Naito, Tatsuhiko Kodama, Sandra Ryeom.   

Abstract

The premetastatic niche is a predetermined site of metastases, awaiting the influx of tumor cells. However, the regulation of the angiogenic switch at these sites has not been examined. Here, we demonstrate that the calcineurin and nuclear factor of activated T cells (NFAT) pathway is activated specifically in lung endothelium prior to the detection of tumor cells that preferentially metastasize to the lung. Upregulation of the calcineurin pathway via deletion of its endogenous inhibitor Dscr1 leads to a significant increase in lung metastases due to increased expression of a newly identified NFAT target, Angiopoietin-2 (ANG2). Increased VEGF levels specifically in the lung, and not other organ microenvironments, trigger a threshold of calcineurin-NFAT signaling that transactivates Ang2 in lung endothelium. Further, we demonstrate that overexpression of DSCR1 or the ANG2 receptor, soluble TIE2, prevents the activation of lung endothelium, inhibiting lung metastases in our mouse models. Our studies provide insights into mechanisms underlying angiogenesis in the premetastatic niche and offer targets for lung metastases.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23954784      PMCID: PMC3763962          DOI: 10.1016/j.celrep.2013.07.021

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  27 in total

1.  Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium.

Authors:  Takashi Minami; Mai Miura; William C Aird; Tatsuhiko Kodama
Journal:  J Biol Chem       Date:  2006-04-20       Impact factor: 5.157

2.  TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice.

Authors:  Abigail F Welford; Daniela Biziato; Seth B Coffelt; Silvia Nucera; Matthew Fisher; Ferdinando Pucci; Clelia Di Serio; Luigi Naldini; Michele De Palma; Gillian M Tozer; Claire E Lewis
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

3.  Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.

Authors:  Sandra Ryeom; Kwan-Hyuck Baek; Matthew J Rioth; Ryan C Lynch; Alexander Zaslavsky; Amy Birsner; Sam S Yoon; Frank McKeon
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

4.  The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.

Authors:  Sachie Hiratsuka; Akira Watanabe; Yoshiko Sakurai; Sachiko Akashi-Takamura; Sachie Ishibashi; Kensuke Miyake; Masabumi Shibuya; Shizuo Akira; Hiroyuki Aburatani; Yoshiro Maru
Journal:  Nat Cell Biol       Date:  2008-09-28       Impact factor: 28.824

5.  The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice.

Authors:  Takashi Minami; Kiichiro Yano; Mai Miura; Mika Kobayashi; Jun-ichi Suehiro; Patrick C Reid; Takao Hamakubo; Sandra Ryeom; William C Aird; Tatsuhiko Kodama
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

6.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

Authors:  Janine T Erler; Kevin L Bennewith; Thomas R Cox; Georgina Lang; Demelza Bird; Albert Koong; Quynh-Thu Le; Amato J Giaccia
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

Review 7.  Modes of resistance to anti-angiogenic therapy.

Authors:  Gabriele Bergers; Douglas Hanahan
Journal:  Nat Rev Cancer       Date:  2008-08       Impact factor: 60.716

8.  The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1.

Authors:  Marie-Pierre Simon; Roselyne Tournaire; Jacques Pouyssegur
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

9.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

Authors:  Michele De Palma; Mary Anna Venneri; Rossella Galli; Lucia Sergi Sergi; Letterio S Politi; Maurilio Sampaolesi; Luigi Naldini
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

10.  Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.

Authors:  Kwan-Hyuck Baek; Alexander Zaslavsky; Ryan C Lynch; Carmella Britt; Yoshiaki Okada; Richard J Siarey; M William Lensch; In-Hyun Park; Sam S Yoon; Takashi Minami; Julie R Korenberg; Judah Folkman; George Q Daley; William C Aird; Zygmunt Galdzicki; Sandra Ryeom
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962

View more
  37 in total

1.  Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown.

Authors:  Shuntaro Ogura; Kaori Kurata; Yuki Hattori; Hiroshi Takase; Toshina Ishiguro-Oonuma; Yoonha Hwang; Soyeon Ahn; Inwon Park; Wataru Ikeda; Sentaro Kusuhara; Yoko Fukushima; Hiromi Nara; Hideto Sakai; Takashi Fujiwara; Jun Matsushita; Masatsugu Ema; Masanori Hirashima; Takashi Minami; Masabumi Shibuya; Nobuyuki Takakura; Pilhan Kim; Takaki Miyata; Yuichiro Ogura; Akiyoshi Uemura
Journal:  JCI Insight       Date:  2017-02-09

Review 2.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

3.  Deletion of Calcineurin Promotes a Protumorigenic Fibroblast Phenotype.

Authors:  Allyson Lieberman; Richard Barrett; Jaewon Kim; Kathy L Zhang; Diana Avery; James Monslow; Hyunsoo Kim; Bang-Jin Kim; Ellen Puré; Sandra Ryeom
Journal:  Cancer Res       Date:  2019-06-12       Impact factor: 12.701

4.  Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies.

Authors:  Zhen Lu; Angelica Ortiz; Ioannis I Verginadis; Amy R Peck; Farima Zahedi; Christina Cho; Pengfei Yu; Rachel M DeRita; Hongru Zhang; Ryan Kubanoff; Yunguang Sun; Andrew T Yaspan; Elise Krespan; Daniel P Beiting; Enrico Radaelli; Sandra W Ryeom; J Alan Diehl; Hallgeir Rui; Constantinos Koumenis; Serge Y Fuchs
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

Review 5.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

Review 6.  Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Authors:  Dai Fukumura; Jonas Kloepper; Zohreh Amoozgar; Dan G Duda; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

Review 7.  Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.

Authors:  Anitha K Shenoy; Jianrong Lu
Journal:  Cancer Lett       Date:  2014-10-31       Impact factor: 8.679

8.  Endothelial GNAQ p.R183Q Increases ANGPT2 (Angiopoietin-2) and Drives Formation of Enlarged Blood Vessels.

Authors:  Lan Huang; Colette Bichsel; Alexis L Norris; Jeremy Thorpe; Jonathan Pevsner; Sanda Alexandrescu; Anna Pinto; David Zurakowski; Robin J Kleiman; Mustafa Sahin; Arin K Greene; Joyce Bischoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-21       Impact factor: 8.311

9.  The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer.

Authors:  Daniel P Hollern; Jordan Honeysett; Robert D Cardiff; Eran R Andrechek
Journal:  Mol Cell Biol       Date:  2014-06-16       Impact factor: 4.272

10.  MicroRNA-150 Suppression of Angiopoetin-2 Generation and Signaling Is Crucial for Resolving Vascular Injury.

Authors:  Charu Rajput; Mohammad Tauseef; Mohammad Farazuddin; Pascal Yazbeck; Md-Ruhul Amin; Vijay Avin Br; Tiffany Sharma; Dolly Mehta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-07       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.